MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/02770903.2026.2696574

Медицинская библиотека · The Journal of asthma : official journal of the Association for the Care of Asthma · 2026

TNFR2 overexpression ameliorates allergic airway inflammation and restores immune homeostasis associated with Hippo pathway modulation in an ovalbumin-induced allergic asthma mouse model.

Lin Dong, Yan Seyan, Weng Guohua

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Asthma remains a major global health burden with limited therapeutic options. Tumor necrosis factor receptor 2 (TNFR2) has been implicated in immune regulation, we aimed to investigate its role and underlying mechanisms in asthma pathogenesis.

METHODS

An ovalbumin (OVA)-induced murine asthma model was established to investigate TNFR2 function. Recombinant adeno-associated virus serotype 9 vectors were administered three weeks prior to OVA sensitization to achieve prophylactic TNFR2 overexpression. Airway inflammation was assessed by histological staining and inflammation scoring. Bronchoalveolar lavage fluid was analyzed for inflammatory cell infiltration. Flow cytometry was employed to determine Th1/Th2 ratios in lymphoid tissues. Cytokine profiles were measured by ELISA. Western blotting and immunohistochemistry were conducted to evaluate Hippo signaling pathway activation.

RESULTS

TNFR2 protein expression was significantly downregulated in asthmatic lung tissues. TNFR2 overexpression markedly attenuated airway inflammation, reduced mucus production, and decreased plasma IgE levels. The treatment restored Th1/Th2 immune balance and modulated cytokine production. Mechanistically, TNFR2 overexpression was associated with altered phosphorylation status of large tumor suppressor kinase (LATS) and yes-associated protein (YAP), suggesting potential involvement of the Hippo signaling pathway.

CONCLUSIONS

These findings demonstrate that prophylactic TNFR2 overexpression ameliorates allergic airway inflammation via immunomodulation, with concomitant modulation of immune responses and Hippo pathway activity, identifying TNFR2 as a potential therapeutic target for asthma.

Для цитирования: Lin Dong, Yan Seyan, Weng Guohua. TNFR2 overexpression ameliorates allergic airway inflammation and restores immune homeostasis associated with Hippo pathway modulation in an ovalbumin-induced allergic asthma mouse model.. The Journal of asthma : official journal of the Association for the Care of Asthma. 2026. DOI: 10.1080/02770903.2026.2696574.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.